Jihong Ma

820 total citations · 1 hit paper
24 papers, 575 citations indexed

About

Jihong Ma is a scholar working on Molecular Biology, Oncology and Hepatology. According to data from OpenAlex, Jihong Ma has authored 24 papers receiving a total of 575 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 7 papers in Oncology and 7 papers in Hepatology. Recurrent topics in Jihong Ma's work include Liver physiology and pathology (7 papers), Nanoplatforms for cancer theranostics (4 papers) and Mitochondrial Function and Pathology (3 papers). Jihong Ma is often cited by papers focused on Liver physiology and pathology (7 papers), Nanoplatforms for cancer theranostics (4 papers) and Mitochondrial Function and Pathology (3 papers). Jihong Ma collaborates with scholars based in China, United States and Romania. Jihong Ma's co-authors include Reza Zarnegar, Marie C. DeFrances, Xinping Tan, John Stoops, Chunbin Zou, Jianhua Luo, Mo Li, Bingteng Xie, Yang Pu and Lida Guo and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Jihong Ma

24 papers receiving 572 citations

Hit Papers

KAT8-catalyzed lactylation promotes eEF1A2-mediated prote... 2024 2026 2025 2024 40 80 120
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. KAT8-catalyzed lactylation promotes eEF1A2-mediated protein synthesis and colorectal carcinogenesis
    2024 134 citations Bingteng Xie, Jie Li et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jihong Ma China 12 306 134 108 102 97 24 575
Sun Y. Kim United States 6 319 1.0× 168 1.3× 50 0.5× 70 0.7× 174 1.8× 6 571
Zhibo Xie China 13 206 0.7× 124 0.9× 67 0.6× 69 0.7× 205 2.1× 24 510
Ru Ji China 9 275 0.9× 148 1.1× 80 0.7× 66 0.6× 185 1.9× 18 552
Chen Zong China 16 291 1.0× 149 1.1× 153 1.4× 207 2.0× 125 1.3× 22 689
Cristina Olgasi Italy 11 357 1.2× 205 1.5× 46 0.4× 25 0.2× 63 0.6× 21 575
Jèssica Mainez Spain 7 280 0.9× 84 0.6× 117 1.1× 75 0.7× 225 2.3× 9 563
Nobuyuki Nishizawa Japan 20 437 1.4× 169 1.3× 59 0.5× 76 0.7× 233 2.4× 50 853
Baruch Bulvik Israel 13 198 0.6× 88 0.7× 118 1.1× 53 0.5× 164 1.7× 17 649

Countries citing papers authored by Jihong Ma

Since Specialization
Citations

This map shows the geographic impact of Jihong Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jihong Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jihong Ma more than expected).

Fields of papers citing papers by Jihong Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jihong Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jihong Ma. The network helps show where Jihong Ma may publish in the future.

Co-authorship network of co-authors of Jihong Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Jihong Ma. A scholar is included among the top collaborators of Jihong Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jihong Ma. Jihong Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ma, Jihong, Haiyan Yang, Xue Tian, et al.. (2024). Matrix metalloproteinase 2‐responsive dual‐drug‐loaded self‐assembling peptides suppress tumor growth and enhance breast cancer therapy. Bioengineering & Translational Medicine. 9(6). e10702–e10702. 3 indexed citations
2.
Yue, Wei, Xinyu Li, Lei Wang, et al.. (2024). PARP inhibitors suppress tumours via centrosome error-induced senescence independent of DNA damage response. EBioMedicine. 103. 105129–105129. 4 indexed citations
3.
Xie, Bingteng, Jie Li, Pengju Zhang, et al.. (2024). KAT8-catalyzed lactylation promotes eEF1A2-mediated protein synthesis and colorectal carcinogenesis. Proceedings of the National Academy of Sciences. 121(8). e2314128121–e2314128121. 134 indexed citations breakdown →
4.
Wang, Pan, Jihong Ma, Qilong Wang, et al.. (2023). Profiling the metabolome of uterine fluid for early detection of ovarian cancer. Cell Reports Medicine. 4(6). 101061–101061. 18 indexed citations
5.
Ma, Jihong, Aimei Li, Xiangyu Zou, et al.. (2023). A dual drug-loaded peptide system with morphological transformation prolongs drug retention and inhibits breast cancer growth. Biomaterials Advances. 154. 213650–213650. 7 indexed citations
6.
Wang, Hui, Wei Wang, Jihong Ma, et al.. (2023). Folate deficiency promotes cervical squamous carcinoma SiHa cells progression by targeting miR-375/FZD4/β-catenin signaling. The Journal of Nutritional Biochemistry. 124. 109489–109489. 3 indexed citations
7.
Xie, Bingteng, Yang Pu, Fan Yang, et al.. (2022). Proteomic Mapping and Targeting of Mitotic Pericentriolar Material in Tumors Bearing Centrosome Amplification. Cancer Research. 82(14). 2576–2592. 11 indexed citations
8.
Yue, Wei, Jihong Ma, Yinan Xiao, et al.. (2022). The Apoptotic Resistance of BRCA1-Deficient Ovarian Cancer Cells is Mediated by cAMP. Frontiers in Cell and Developmental Biology. 10. 889656–889656. 8 indexed citations
9.
Ma, Jihong, Xinping Tan, Yong‐Kook Kwon, et al.. (2021). A Novel Humanized Model of NASH and Its Treatment With META4, A Potent Agonist of MET. Cellular and Molecular Gastroenterology and Hepatology. 13(2). 565–582. 14 indexed citations
10.
Zhang, Na, Rui Yang, Yanyan Shi, et al.. (2021). Mitochondrial proteome of mouse oocytes and cisplatin-induced shifts in protein profile. Acta Pharmacologica Sinica. 42(12). 2144–2154. 8 indexed citations
11.
Xie, Bingteng, Xiaoling Liang, Wei Yue, et al.. (2021). Targeting cytokinesis bridge proteins to kill high-CIN type tumors. Fundamental Research. 1(6). 752–766. 8 indexed citations
12.
Wang, Pan, Xiaoling Liang, Wenjing Li, et al.. (2020). Down‐regulation of endothelial protein C receptor promotes preeclampsia by affecting actin polymerization. Journal of Cellular and Molecular Medicine. 24(6). 3370–3383. 9 indexed citations
13.
Ma, Jihong, et al.. (2019). MicroRNA-29-3p Regulates Hepatocellular Carcinoma Progression Through NF-κB Pathway. Clinical Laboratory. 65(05/2019). 9 indexed citations
14.
15.
Seneviratne, Danushka S., Jihong Ma, Xinping Tan, et al.. (2014). Genomic Instability Causes HGF Gene Activation in Colon Cancer Cells, Promoting Their Resistance to Necroptosis. Gastroenterology. 148(1). 181–191.e17. 40 indexed citations
16.
Ma, Jihong, Chunbin Zou, Lida Guo, et al.. (2013). Novel Death Defying Domain in Met Entraps the Active Site of Caspase-3 and Blocks Apoptosis in Hepatocytes. Hepatology. 59(5). 2010–2021. 21 indexed citations
17.
Ma, Jihong, Xinping Tan, John Stoops, et al.. (2011). A hepatocyte growth factor receptor (Met)−insulin receptor hybrid governs hepatic glucose metabolism. Nature Medicine. 17(12). 1577–1584. 86 indexed citations
18.
Ma, Jihong, Marie C. DeFrances, Chunbin Zou, et al.. (2009). Somatic mutation and functional polymorphism of a novel regulatory element in the HGF gene promoter causes its aberrant expression in human breast cancer. Journal of Clinical Investigation. 119(3). 478–491. 42 indexed citations
19.
Zou, Chunbin, Jihong Ma, Xue Wang, et al.. (2007). Lack of Fas antagonism by Met in human fatty liver disease. Nature Medicine. 13(9). 1078–1085. 77 indexed citations
20.
Ma, Jihong. (2005). Germline and somatic mutation in the HGF gene promoter causes its aberrant expression in human carcinoma and establishes an HGF-Met autocrine loop.. Cancer Research. 65. 10–11. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sun Y. Kim Breakdown of academic impact, for papers by Zhibo Xie Breakdown of academic impact, for papers by Ru Ji Breakdown of academic impact, for papers by Chen Zong Breakdown of academic impact, for papers by Cristina Olgasi Breakdown of academic impact, for papers by Jèssica Mainez Breakdown of academic impact, for papers by Nobuyuki Nishizawa Breakdown of academic impact, for papers by Baruch Bulvik
Rankless by CCL
2026